IChenopodium quinoa/I’s Ingredients Improve Control of the Hepatic Lipid Disturbances Derived from a High-Fat Diet

• Published in: Foods 2023-09, Vol.12 (17)
• Main Authors: Garcia Tejedor, Aurora, Haros, Claudia Monika, Laparra Llopis, José Moisés
• Format: Article
• Language: English
• Subjects: Amino acids; Ethylenediaminetetraacetic acid; Fatty acids; Quinoa; Type 2 diabetes
• ISSN: 2304-8158; 2304-8158
• DOI: 10.3390/foods12173321

This study explored the effects of Chenopodium quinoa’s ingredients on the major lipids’ hepatic profile and the functional selective differentiation of monocyte-derived macrophages and innate lymphoid cells in mice on a high-fat diet. Six-week-old Rag2[sup.-/-] and Rag2[sup.-/-]Il2[sup.-/-] mice received (12 days) a low-molecular-weight protein fraction (LWPF) or the lipid fraction (qLF) obtained from the cold pressing of C. quinoa’s germen. At the end of the experiment, mouse serum and liver tissue were collected. The differences in triglycerides, phospholipids, and the major lipids profile were analyzed. Infiltrated monocyte-derived macrophages and innate lymphoid cells (ILCs) and the expression of liver metabolic stress-related mRNA were measured. In the Rag2[sup.-/-] mice, feeding them LWPF appeared to improve, to a larger extent, their hepatic capacity to utilize fatty acids in comparison to the qLF by preventing the overwhelming of triglycerides (TGs), despite both reducing the hepatic lipid accumulation. An analysis of the hepatic major lipids profile revealed significant increased variations in the PUFAs and phospholipid composition in the Rag2[sup.-/-] mice fed with the LWPF or LF. The Rag2[sup.-/-]Il2[sup.-/-] mice, lacking innate and adaptive lymphocytes, seemed resistant to mobilizing hepatic TGs and unresponsive to lipid accumulation when fed with the LF. Notably, only the Rag2[sup.-/-] mice fed with the LWPF showed an increased proportion of hepatic CD68+F4/80+ cells population, with a better controlled expression of the innate immune ‘Toll-like’ receptor (TLR)-4. These changes were associated with an oriented expansion of pluripotential CD117+ cells towards ILC2s (CD117+KLRG1+). Thus, C. quinoa’s ingredients resulted in being advantageous for improving the mechanisms for controlling the hepatic lipotoxicity derived from a high-fat diet, promoting liver macrophage and ILCs expansion to a selective functional differentiation for the control of HFD-driven immune and metabolic disturbances.